BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukaemia (CML), tyrosine phosphorylation of β-catenin on residues Y86 and Y654 by the oncogenic fusion protein BCR-ABL led to its reduced affinity for the DC, and subsequent increase and activity in the nucleus [89].